
### [NCIT:C4074](http://purl.obolibrary.org/obo/NCIT_C4074)
**Label:** Centroblastic Lymphoma

**Subclasses:** [NCIT:C8926](http://purl.obolibrary.org/obo/NCIT_C8926) (Recurrent Centroblastic Lymphoma), [NCIT:C8927](http://purl.obolibrary.org/obo/NCIT_C8927) (Refractory Centroblastic Lymphoma), [NCIT:C7248](http://purl.obolibrary.org/obo/NCIT_C7248) (Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C8931](http://purl.obolibrary.org/obo/NCIT_C8931) (Stage IV Centroblastic Lymphoma), [NCIT:C8930](http://purl.obolibrary.org/obo/NCIT_C8930) (Stage III Centroblastic Lymphoma), [NCIT:C8928](http://purl.obolibrary.org/obo/NCIT_C8928) (Stage I Centroblastic Lymphoma), [NCIT:C8929](http://purl.obolibrary.org/obo/NCIT_C8929) (Stage II Centroblastic Lymphoma), 

**Class expressions from DL-Learner:**

- [NCIT:C36449](http://purl.obolibrary.org/obo/NCIT_C36449) (Clonal BCL6 Gene Rearrangement) 56.25%
- [NCIT:C36442](http://purl.obolibrary.org/obo/NCIT_C36442) (Clonal BCL2 Gene Rearrangement) 56.25%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and [NCIT:C36333](http://purl.obolibrary.org/obo/NCIT_C36333) (Clonal Gene Rearrangement) 56.25%
- Thing 52.88%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) 41.61%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C38666](http://purl.obolibrary.org/obo/NCIT_C38666) (Monomorphic Cellular Infiltrate))) 41.61%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C38665](http://purl.obolibrary.org/obo/NCIT_C38665) (Chest Pain))) 41.61%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C38661](http://purl.obolibrary.org/obo/NCIT_C38661) (Composite Lymphoma))) 41.61%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C38660](http://purl.obolibrary.org/obo/NCIT_C38660) (Neoplastic Large B-Lymphocyte with Pale Cytoplasm))) 41.61%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C3866](http://purl.obolibrary.org/obo/NCIT_C3866) (Esophageal Leiomyoma))) 41.61%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C38658](http://purl.obolibrary.org/obo/NCIT_C38658) (Transformed Peripheral B-Lymphocyte))) 41.61%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C38657](http://purl.obolibrary.org/obo/NCIT_C38657) (Neoplastic Immunoblast-Like B-Lymphocyte))) 41.61%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C38656](http://purl.obolibrary.org/obo/NCIT_C38656) (ALK Kinase Overexpression))) 41.61%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C38655](http://purl.obolibrary.org/obo/NCIT_C38655) (Bulky Disease))) 41.61%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C38650](http://purl.obolibrary.org/obo/NCIT_C38650) (Defective Mu Heavy Chain Present))) 41.61%


